NCT06719050Not yet recruiting
Telehealth-Based Chronic Disease Management for Type 2 Diabetes
Application and Evaluation of Telehealth-Based Chronic Disease Management for Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 5 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study will be conducted from enrollment until the end of the six-month follow-up period. This study aims to assess the impact of the Internet hospital online + offline integrated chronic disease management model on patients with type 2 diabetes mellitus. It will also evaluate the economic impact of the model and identify the characteristics of the appropriate population for the model. Finally, it will develop a toolkit to help manage chronic diseases. The study will include 1,636 patients with type 2 diabetes who did not reach the standard of control target of glucose, blood pressure or LDL at the endocrine outpatient clinic and inpatient wards of the Third Hospital of Peking University. We will collect information from participants before the study starts. And the patients will be followed up for 6 months from enrollment. The study management mode included online and offline integrated management in the Internet hospital, and routine offline management mode. After completing the enrollment and assessment, we will arrange outpatient follow-up and management according to the current status, doctor's requirements, and study subjects' needs.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1636 (estimated)
- First submitted
- 28 Nov 2024
- Start date
- 18 Dec 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Zeng Lin, Ph. D.
- Diseases
- Type 2 diabetes
- NCT number
- NCT06719050
What you commit to
- Study type: Observational
- Planned participants: 1636
- From 18 Dec 2024 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Mental illness, cognitive dysfunction;
- Other diseases and complex conditions (untreated tumors, heart disease within 3 months);
- Patients with severe chronic complications of diabetes in critical condition (blindness, vision deterioration, new onset of ASCVD symptoms);
- Those who are unsuitable for the study: infection, fracture, trauma, foot ulceration, edema, blindness, cardiovascular emergencies, coma, etc;
Lab values
- Acute complications of diabetes, severe hyperglycemia, fasting glucose greater than 16.9 mmol / L, random glucose greater than 20 mmol / L. Diabetic ketoacidosis and hypoglycemic coma that are not suitable for online management of diabetes emergencies;
Other
- Those who have not signed the informed consent form.
Who the study is looking for
- 18-70 years old;
- Confirmed diagnosis of type 2 diabetes mellitus;
- Ability to use smartphones to participate in online diagnosis and treatment;
- Ability of the patient or relatives to assist the patient in self-monitoring of blood glucose;
- Failure to meet control targets: glycated hemoglobin ≥7. 0%, or LDL-C ≥ 2.6 mmol/L (and ASCVD or definite atherosclerosis with stenosis ≥ 1.8 mmol/L), or blood pressure \> 130% and ≥ 1.8 mmol/kg. L), or blood pressure over 130/80 mmHg.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.